Linh Hoang, MD, PhD, is the Chief Executive Officer of HistoWiz, the New York based digital pathology company building PathologyMap, a platform that automates histology and connects researchers to top pathologists on demand. A physician-scientist turned operator, he trained at the University of Pennsylvania, cut his teeth at Boston Consulting Group, and ran businesses at Thermo Fisher and PerkinElmer before leading two diagnostics companies as CEO, Boston Microfluidics and its successor Weavr Health, ahead of joining HistoWiz in October 2022.
Mike Stapleton is the Chief Business Officer of QbDVision, the Austin-based software company building a Digital CMC platform for pharma and biotech. He spent three decades moving between the lab bench, the boardroom, and the consulting deck - senior scientist at BP, COO at Accelrys, leader at Life Technologies, PerkinElmer, Merck, Microsoft, and Accenture - before joining QbDVision's board and then stepping in to run its commercial strategy. His argument is contrarian for a software executive: the bottleneck in drug development is not the platform, it is the people willing to standardize how an industry handles its data.